On Cancer: Research

Share
Print
and/or
658 Blog posts found

Announcement

Three Scientists Are Named Winners of the Paul Marks Prize for Cancer Research

Memorial Sloan Kettering has named three winners of this year’s Paul Marks Prize for Cancer Research, an award that recognizes promising investigators.

Nathanael Gray, Joshua Mendell, and Christopher Vakoc

Finding

Genetic Variations Help Explain Why Immunotherapy Works Differently in Different People

A new study reports a possible way to quantify how efficient the immune system is at detecting cancer, and therefore how likely it is that a person will respond to immunotherapy.

Colorful illustration of people overlaid on a world map

In the Lab

Newly Discovered Immune Cell Subtypes Could Shake Up Immunotherapy

Dendritic cells, the guards of the immune system, have a previously unrecognized division of labor.

a colorful dendritic cell

In the Clinic

6 Breakthroughs That Are Changing Chemotherapy for People with Breast Cancer

Discover some of the latest innovations in chemotherapy for breast cancer.

MSK patient receiving chemotherapy

In the Lab

Targeting Errors in How Proteins Are Made Is a Promising Approach for Cancer Treatment

MSK studies look at the role of RNA splicing factors in acute myeloid leukemia and melanoma.

Physician-scientist Omar Abdel-Wahab in his lab.

In the Lab

Scientists Create the First Human-Tumor-Derived Model for Studying Rectal Cancer

Scientists at Memorial Sloan Kettering have created a model of rectal cancer using human-tumor-derived organoids.

Blue cells on a black background

Finding

Research Points to a Potential New Approach for Treating Anemia

A class of drugs originally developed to treat certain neurological disorders appears to boost the production of red blood cells.

Red blood cells

Feature

Getting to the Root of Pediatric Cancers

MSK Kids is leading a major effort to fully deliver on the promise of precision medicine for our youngest patients.

Rihanna sitting in a chair outside

Q & A

MSK Program Focuses on Speeding Up Development of New Leukemia Treatments

Learn about MSK's new Center for Drug Development in Leukemia, which will offer more clinical trials for many types of leukemia.

MSK hematologic oncologist Eytan Stein